I (along with everyone else) picked on KV Pharmaceuticals earlier this year for the pricing decisions they made in introducing their premie drug Makena. Now it appears that there are some quality/cosnistency issues with at least some compounders of the drug. The FDA is looking into it.
FDA Probes Compounded Versions Of Makena // Pharmalot.
I present this in my effort to be "fair and balanced" hehehe.
Posted by Bruce Lehr Nov 11 2011
Comments